Brief: Cullinan Oncology Reports Fourth Quarter And Full Year 2022 Financial Results

Cullinan Therapeutics

09/03/2023 12:38

March 9 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
    * CULLINAN ONCOLOGY INC: INITIAL CLINICAL DATA UPDATES FOR
CLN-049
AND CLN-619 ON TRACK FOR MID-2023
    * CULLINAN ONCOLOGY INC: QTRLY LOSS PER SHARE $ 0.59
    * CULLINAN ONCOLOGY INC: CASH AND INVESTMENTS WERE $550.1
MILLION
AS OF DECEMBER 31, 2022
    * CULLINAN ONCOLOGY INC: EXPECTS ITS CASH RESOURCES TO
PROVIDE
RUNWAY INTO 2026 BASED ON ITS CURRENT OPERATING PLAN

Source text for Eikon:  ID:nGNXbY87JP 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))